4 Preformulation Flashcards
What is preformulation?
Gathering information regarding properties which may have a bearing on product formulations.
Problems are identified and ways around it can be established.
What is the object of dosage form development?
To develop a stable, bioavailable product with good acceptance.
What must the formulator develop?
A specific detailed formulation procedure and define specification of raw , excipients and finished product.
What are organoleptic properties?
The description of drug substance, including colour, odor and taste.
How do we remedy objectionable color?
By use of a colouring agents or coating the tablet
How can we remedy objectionable odors?
A coating or the inclusion of an aromatic excipient
How can we remedy objectionable taste?
By use of a flavouring agent, a coating or use of an insoluble salt form
What are the 5 tastes recognized?
Bitter, sour, sweet, salty and umami
What are the groups associated with each taste?
Bitter: Amine groups (alkaloid quinine) Sour: Acids (citric acid) Sweet: Hydroxyl groups (glycerol, sugars) Salty: Inorganic salts (NaCl, KCl) Umami: Some amino acids (glutamate)
What should you know about the purity? Why?
Must know and define the level of material purity and what impurities it may present
Trace amounts of metal can affect stability, impurities may be toxic.
May require addition of excipients or limit test development.
What are micromeretics?
The particle size, shape and surface area of drug material. Plays role in homogeneity of tablet.
Small particle size increases surface area which will be in contact with excipient, oxygen and moisture.
What problems arise from milling?
Static electricity, agglomeration and polymorph formation.
Why is solubility important?
The product must dissolve in gastrointestinal fluids prior to absorption.
Usually better dissolution means better bioavailability.
Solubility >1% does not present dissolution/bioavailabilty problems.
What relationships must we know to solubility?
The relationship between medium pH, solubility and stability.
How do we determine potentially useful salts?
For HCl salts of oral products you must assess the common ion effect.
Determine the pKa of drug if ionizable.
What do you do if the drug is not ionizable?
May include the use of a metastable polymorph, use of complexes, solid solution techniques, incorporation of surfactants and particle size reduction (micronization).
Why would we want reduced solubility?
For stability and organoleptic reasons.
What if kd is slower than ka?
Then absorption is limited by dissolution rate.
Any change in kd will affect absorption rate.